Introducing MosaiQ™ by Quotient
The potential to improve patient outcomes with better matched blood. The future, made possible.
The timely delivery of safe and compatible blood products to patients is critical. MosaiQ is the world’s first fully-automated testing solution that will allow for rapid, extensive antigen typing/antibody identification of donor and patient blood utilizing a single Microarray (or consumable). These turn-key, extended phenotyping capabilities enable the prospect of better matched blood and reduced risk of alloimmunization and other adverse effects arising from a transfusion.
By offering the most comprehensive testing menu on a single automated testing platform, MosaiQ will offer the potential for improved clinical decision making and considerable operating efficiencies, both in a donor-testing and patient-testing environment.
MosaiQ is also being developed to streamline all mandatory transfusion transmissible infection screening for donor red blood cells and plasma.
A novel, comprehensive automated testing solution primed to establish new standards of excellence in transfusion medicine worldwide.
The MosaiQ platform enables…
- Unprecedented characterization of donor or patient blood via highly characterized antigen and antibody panels using just a single tube of sample
- Workflow efficiencies through walk-away-capable processing of approximately 1000 samples in a single 8-hour shift
- Enhanced resource management capabilities from a platform designed for ease of use, simplified reagent and consumable needs, and significantly reduced waste
- Reliable and reproducible results